SCHEMBL30263259

SCHEMBL30263259

COCCOc1ccccc1-c1csc(-c2ccccc2C(N)=O)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.48
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ATP4A P20648 2/20 0.44
ATP4B P51164 2/20 0.44
C1S P09871 1/20 0.43
EIF4E P06730 2/20 0.43
SREBF2 Q12772 1/20 0.43
HTT P42858 1/20 0.42
MEN1 O00255 1/20 0.42
NR1I2 O75469 1/20 0.42
LMNA P02545 1/20 0.42
CHRM2 P08172 1/20 0.42
CYP3A4 P08684 1/20 0.42
ADRA2A P08913 1/20 0.42
MAPT P10636 1/20 0.42
OPRK1 P41145 1/20 0.42
HTR2B P41595 1/20 0.42
SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30263307 0.88 CYP19A1 (0.42) CYP19A1NPC1RAB9ASMN1; SMN2ATP4A
SCHEMBL30263311 0.81 JAK2 (0.48) HTTMEN1MAPTKMT2ACYP1A1
SCHEMBL23835432 0.77 LMNA (0.67) SMN1; SMN2HTTMEN1NR1I2LMNA
SCHEMBL5968562 0.74 RAB9A (0.62) NPC1RAB9ASMN1; SMN2C1SEIF4E
SCHEMBL22728617 0.74 LMNA (0.59) NPC1RAB9ASMN1; SMN2HTTMEN1
SCHEMBL20333484 0.74 NPC1 (0.62) CYP19A1NPC1RAB9ASMN1; SMN2EIF4E
SCHEMBL30263367 0.74 CYP19A1 (0.57) CYP19A1NPC1RAB9ASMN1; SMN2EIF4E
SCHEMBL27965806 0.73 RAB9A (0.78) CYP19A1NPC1RAB9ASMN1; SMN2EIF4E
SCHEMBL28730343 0.73 LMNA (0.64) NPC1RAB9ASMN1; SMN2HTTMEN1
SCHEMBL30263274 0.72 ADORA3 (0.65) NPC1RAB9ASMN1; SMN2HTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4161921-A1 COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF Anima Biotech Inc. (US) 2023-04-12 EP disclosed